A multicenter, open-label, pharmacokinetic drug interaction study of erenumab (AMG 334) and a combined oral contraceptive in healthy female subjects

Authors
Category Primary study
ConferenceHeadache
Year 2017
This article has no abstract
Epistemonikos ID: 0ec743ab2eab38071a4999d20df3f58318b82531
First added on: Apr 29, 2026